Subscribe
Finding quality compounders amid a fundamentally changed backdrop
It is designed to exploit mean reversion, a compelling investing concept, but there are issues to iron out
Earnings growth forecasts must be balanced against valuation
Our screen’s nuanced take on metric-based investing has served up 25 names for 2025
Options for growth at a more reasonable price
The Stalwarts screen picks another batch of companies with strong balance sheets, good growth opportunities and products that are always in demand
How will our Double Up screen deal with ongoing market shocks?
In case trade headaches hit big dividend payers is it time to look at mid-caps?
Despite a lack of bids, the first outing for our ‘takeover screen’ shows it can pay to think like a buyer
Trade war should prompt reflection over which shares are quality compounders